Forest Laboratories Holdings Limited

Bermudes

 
Quantité totale PI 76
Rang # Quantité totale PI 17 656
Note d'activité PI 1,9/5.0    13
Rang # Activité PI 67 080
Parent Allergan plc

Brevets

Marques

21 0
6 0
49 0
0
 
Dernier brevet 2024 - Treatment of constipation-predom...
Premier brevet 1992 - Method of lowering the blood pre...

Derniers inventions, produits et services

2023 Invention Treatment of constipation-predominant irritable bowel syndrome. The invention provides methods f...
Invention Low-dose stable formulations of linaclotide. The present invention relates to stable pharmaceuti...
Invention Delayed release compositions of linaclotide. The present invention relates to delayed release ph...
Invention Stable formulations of linaclotide. The present invention relates to stable pharmaceutical compo...
Invention Stable solid formulation of gc-c receptor agonist polypeptide suitable for oral administration. ...
2021 Invention Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration....
2020 Invention Modified release formulations of memantine oral dosage forms. The present invention provides pha...
Invention Stable dosage forms of levomilnacipran. The present invention relates to stable dosage forms of ...
2019 Invention Linaclotide compositions. The present invention is directed to stable linaclotide compositions a...
2018 Invention Nmda receptor modulators and uses thereof. Disclosed are compounds having enhanced potency in th...
2017 Invention Donepezil compositions and methods of treating alzheimers disease. Oral dosage forms comprising ...
Invention Compositions and methods for treating bacterial infections using ceftaroline. The present invent...
Invention Orally dissolving formulations of memantine. Orally dissolving formulations, e.g., tablets (ODTs...
Invention Novel crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide ...
2016 Invention Modified and immediate release formulations of memantine. The present invention provides immedia...
Invention Modified release formulations of memantine oral dosage forms. The present invention provides phar...
2015 Invention Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium...
Invention Soluble dosage forms containing cephem derivatives suitable for parenteral administration. The p...
Invention Roflumilast compositions for the treatment of copd. The present invention relates to pharmaceuti...
Invention Donepezil compositions and method of treating alzheimer's disease. Oral dosage forms comprising d...
Invention Donepezil compositions and methods of treating alzheimer's disease. Oral dosage forms comprising ...
2014 Invention Delayed release compositions of linaclotide. The present invention relates to delayed release pha...
Invention Pharmaceutical formulations comprising vilazodone. The present invention provides an immediate re...
Invention Combination therapy for the treatment of nosocomial pneumonia. The present invention relates to ...